skip to main content
previous page 1 Resultados 2 3 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: NUS Single-Journal Subscriptions remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Preliminary results from a phase 1/2 study of co-stimulatory bispecific PSMAxCD28 antibody REGN5678 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Preliminary results from a phase 1/2 study of co-stimulatory bispecific PSMAxCD28 antibody REGN5678 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Stein, Mark N. ; Zhang, Jingsong ; Kelly, William Kevin ; Wise, David R ; Tsao, Kai ; Carneiro, Benedito A. ; Falchook, Gerald Steven ; Sun, Furong ; Govindraj, Shilpa ; Sims, Jennifer S ; Zhu, Min ; Seebach, Frank A. ; Lowy, Israel ; Thanigaimani, Pradeep ; Sandigursky, Sabina ; Miller, Elizabeth

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.154-154 [Periódico revisado por pares]

Texto completo disponível

12
A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update

Segal, Neil Howard ; Pelster, Meredith ; Girda, Eugenia ; Fong, Lawrence ; Olszanski, Anthony J. ; Han, Hyunsil ; Casey, Kerry A. ; Li, Siyu ; Welf, Erik ; Chen, Chieh-I ; Skokos, Dimitris ; Seebach, Frank A. ; Lowy, Israel ; Fury, Matthew G. ; Mathias, Melissa Divya ; Lakhani, Nehal J.

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS277-TPS277 [Periódico revisado por pares]

Texto completo disponível

13
A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results

Segal, Neil Howard ; Girda, Eugenia ; Sohal, Davendra ; Lakhani, Nehal J. ; Olszanski, Anthony J. ; Fong, Lawrence ; Kinnaman, Michael David ; Han, Hyunsil ; Skokos, Dimitris ; Casey, Kerry A. ; Wang, JuAn ; Wang, Bei ; Hao, Yi ; Li, Siyu ; Ganguly, Samit ; Lowy, Israel ; Seebach, Frank A. ; Mathias, Melissa Divya ; Johnson, Melissa Lynne

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.2503-2503 [Periódico revisado por pares]

Sem texto completo

14
Combination of cemiplimab and ISA101b vaccine for the treatment of recurrent/metastatic HPV16 cervical cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Combination of cemiplimab and ISA101b vaccine for the treatment of recurrent/metastatic HPV16 cervical cancer

Lorusso, Domenica ; Oaknin, Ana ; Santos Borges, Giuliano ; Damian, Fernanda ; Ottevanger, P. B. ; Van Gorp, Toon ; Paiva, Carlos Eduardo ; Kroep, Judith R. ; Kim, Yong Man ; Kim, Hee Seung ; Lee, Jae-Kwan ; Melief, Cornelis JM ; Hooftman, Leon ; Jamil, Shaheda Jamil ; Yoo, Suk-Young ; Seebach, Frank A. ; Lowy, Israel ; Fury, Matthew G. ; Mathias, Melissa Divya ; Colombo, Nicoletta

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.5522-5522 [Periódico revisado por pares]

Sem texto completo

15
A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti–PD-1) in patients with metastatic castration-resistant prostate cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti–PD-1) in patients with metastatic castration-resistant prostate cancer

Zhang, Jingsong ; Stein, Mark N. ; Kelly, William Kevin ; Tsao, Che-Kai ; Falchook, Gerald Steven ; Xu, Yuanfang ; Seebach, Frank A. ; Lowy, Israel ; Mohan, Kosalai Kal ; Kroog, Glenn ; Miller, Elizabeth

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS174-TPS174 [Periódico revisado por pares]

Texto completo disponível

16
A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with mesenchymal epithelial transition factor (MET)-overexpressing NSCLC
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with mesenchymal epithelial transition factor (MET)-overexpressing NSCLC

Drilon, Alexander E. ; Awad, Mark M. ; Gadgeel, Shirish M. ; Villaruz, Liza C ; Sabari, Joshua K. ; Perez, Javier ; Daly, Christopher ; Patel, Shraddha ; Li, Siyu ; Seebach, Frank A. ; Lowy, Israel ; Magnan, Heather D. ; Rietschel, Petra

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS8593-TPS8593 [Periódico revisado por pares]

Texto completo disponível

17
Peripheral myeloid cells as prognostic markers in patients (pts) with non-small cell lung cancer (NSCLC) treated with cemiplimab: Pooled analysis of EMPOWER-Lung 1 and EMPOWER-Lung 3 phase 3 trials
Material Type:
Artigo
Adicionar ao Meu Espaço

Peripheral myeloid cells as prognostic markers in patients (pts) with non-small cell lung cancer (NSCLC) treated with cemiplimab: Pooled analysis of EMPOWER-Lung 1 and EMPOWER-Lung 3 phase 3 trials

Murray, Joseph Christopher ; McIntyre, Debra AG ; Anagnostou, Valsamo ; Brahmer, Julie R. ; Meisel, Alexander ; Sezer, Ahmet ; Gogishvili, Miranda ; Melkadze, Tamar ; Baramidze, Ana ; Makharadze, Tamta ; He, Adam ; Li, Siyu ; Jankovic, Vladimir ; Seebach, Frank A. ; Rietschel, Petra ; Kim, Young J. ; Gullo, Giuseppe ; Pouliot, Jean-Francois

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9028-9028 [Periódico revisado por pares]

Texto completo disponível

18
A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti-PD-1) in patients with metastatic castration-resistant prostate cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti-PD-1) in patients with metastatic castration-resistant prostate cancer

Drake, Charles G. ; Zhang, Jingsong ; Stein, Mark N. ; Xu, Yuanfang ; Seebach, Frank A. ; Lowy, Israel ; Mohan, Kosalai Kal ; Kroog, Glenn ; Miller, Elizabeth

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS5592-TPS5592 [Periódico revisado por pares]

Texto completo disponível

19
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Stratigos, Alexander J. ; Sekulic, Aleksandar ; Peris, Ketty ; Bechter, Oliver ; Prey, Sorilla ; Lewis, Karl D. ; Basset-Seguin, Nicole ; Chang, Anne Lynn S. ; Dalle, Stéphane ; Fernández Orland, Almudena ; Licitra, Lisa ; Robert, Caroline ; Ulrich, Claas ; Hauschild, Axel ; Migden, Michael R. ; Dummer, Reinhard ; Yoo, Suk-Young ; Okoye, Emmanuel ; Bassukas, Ioannis ; Loquai, Carmen ; De Giorgi, Vincenzo ; Eroglu, Zeynep ; Gutzmer, Ralf ; Ulrich, Jens ; Puig, Susana ; Inocencio, Timothy J. ; Chen, Chieh-I ; LaFontaine, Patrick R. ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew G.

Journal of the American Academy of Dermatology, 2024-02, Vol.90 (2), p.414-418 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

20
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥ 50%: EMPOWER-Lung 1 subgroup analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥ 50%: EMPOWER-Lung 1 subgroup analysis

Ozguroglu, Mustafa ; Sezer, Ahmet ; Kilickap, Saadettin ; Gumus, Mahmut ; Bondarenko, Igor ; Gogishvili, Miranda ; Turk, Haci M. ; Cicin, Irfan ; Bentsion, Dmitry ; Gladkov, Oleg ; Clingan, Philip R. ; Sriuranpong, Virote ; Rizvi, Naiyer A. ; McGinniss, Jennifer ; Pouliot, Jean-Francois ; Lee, Sue ; Seebach, Frank A. ; Lowy, Israel ; Gullo, Giuseppe ; Rietschel, Petra

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9085-9085 [Periódico revisado por pares]

Texto completo disponível

previous page 1 Resultados 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (25)

Data de Publicação 

De até
  1. Antes de1999  (1)
  2. 1999Até2007  (2)
  3. 2008Até2017  (1)
  4. 2018Até2020  (5)
  5. Após 2020  (21)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.